TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
RF Business Division		11.81B	12.40B	26.43B	24.43B	48.35B
RF Business Division Growth		-4.76%	-53.09%	8.20%	-49.47%	-4.96%
Pharmaceutical/Bio Business Division		25.89B	16.49B	15.23B	13.02B	14.16B
Pharmaceutical/Bio Business Division Growth		57.05%	8.24%	16.99%	-8.03%	20.66%
Other Sector		-	-	-	-1.21B	-
Elimination of Internal Transactions, Etc.		-1.40B	-1.06B	-3.82B	-3.10B	-5.91B
Total		36.31B	27.83B	37.84B	33.14B	56.59B
Total Growth		30.46%	-26.46%	14.18%	-41.44%	-1.94%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea		30.21B	18.64B	20.00B	19.15B	26.49B
South Korea Growth		62.07%	-6.78%	4.39%	-27.69%	-16.59%
Asia		2.86B	6.00B	14.88B	11.09B	25.38B
Asia Growth		-52.27%	-59.68%	34.21%	-56.32%	22.73%
North America		3.23B	3.19B	2.97B	2.90B	1.11B
North America Growth		1.32%	7.54%	2.27%	161.56%	-42.85%
Oceania		-	-	-	-	3.62B
Oceania Growth		-	-	-	-	8.39%
Total		36.31B	27.83B	37.84B	33.14B	56.59B
Total Growth		30.46%	-26.46%	14.18%	-41.44%	-1.94%

Source: S&P Global Market Intelligence.